TetraLogic Pharmaceuticals Corporation
TLOG
TLOG was delisted on the 3rd of November, 2016.
28 hedge funds and large institutions have $37.7M invested in TetraLogic Pharmaceuticals Corporation in 2014 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 13 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less capital invested
Capital invested by funds: $43.4M → $37.7M (-$5.67M)
20% less funds holding
Funds holding: 35 → 28 (-7)
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
+$245K |
| 2 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$87.2K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$80.1K |
| 4 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$58.2K |
| 5 |
FWC
First Washington Corp
Seattle,
Washington
|
+$49.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$1.14M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$538K |
| 3 |
Bank of New York Mellon
New York
|
-$234K |
| 4 |
First Eagle Investment Management
New York
|
-$218K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$183K |
TLOG Hedge Fund Activity: Q2 2014 in Review
28 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q2 2014, worth a combined $37.7M — down 13% from $43.4M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of TLOG and 6 opened new positions — a net loss of 7 holders — while 6 trimmed existing stakes and 10 added.
The largest buyer was Pine River Capital Management, adding an estimated $245K. The largest seller was Nicholas Investment Partners, exiting entirely with an estimated $1.14M sold.
- 28 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q2 2014, down from 35 in Q1 2014.
- Funds reported $37.7M of TetraLogic Pharmaceuticals Corporation stock for Q2 2014, down 13% quarter-over-quarter.
- 6 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q2 2014 and 13 closed out, a net change of -7 holders.
- The largest TetraLogic Pharmaceuticals Corporation buyer in Q2 2014 was Pine River Capital Management, an estimated $245K added.
- The largest TetraLogic Pharmaceuticals Corporation seller in Q2 2014 was Nicholas Investment Partners, an estimated $1.14M sold.
Based on aggregated 13F filings for Q2 2014.